Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received
Drugs
Pharma
Drugs
Health
Pharma
‘Every two minutes, a woman dies during childbirth, pregnancy’
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to
Drugs
Medical
Pharma
Merck’s pill fails to prevent COVID-19 infection among households
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Medical
Pharma
Wipro unveils ‘tamper-proof’ self-verifiable digital wallet
India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to
Health
Medical
Large study provides clues on immunity against Covid reinfection
A large study provides clues on how long immunity lasts against Covid reinfection and does vaccination help in reducing its severity
Climate
Health
Reconstruction challenge in Turkey, Syria as toll at 41,000
About 1.5 million are homeless in Turkey after the largest earthquake disaster devastated the country, with 210 million tonnes of rubble awaiting clearance,
Drugs
Pharma
Zydus gets FDA green light for drugs to treat diabetes, shingles
Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other
Drugs
Medical
Pharma
FDA gives nod for Apellis’ injection to treat geographic atrophy
Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.
Drugs
Health
Pharma
Embedded LEDs may aid future cancer immunotherapies
Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.
Drugs
Pharma
Glenmark gets 2nd FDA nod for high blood sugar drug
Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.